Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
1.730
-0.010 (-0.57%)
At close: Mar 9, 2026, 4:00 PM EDT
1.770
+0.040 (2.31%)
After-hours: Mar 9, 2026, 7:59 PM EDT

Inovio Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
119661393891,0501,499
Upgrade
Market Cap Growth
105.28%-52.55%-64.23%-62.93%-29.98%354.28%
Upgrade
Enterprise Value
78-621406881,237
Upgrade
Last Close Price
1.731.836.1218.7259.88106.20
Upgrade
PS Ratio
651.85303.38167.3337.93591.53202.30
Upgrade
PB Ratio
-0.961.191.752.633.25
Upgrade
P/TBV Ratio
-0.961.191.862.723.35
Upgrade
EV/Sales Ratio
428.18-1.8613.62387.68166.88
Upgrade
Debt / Equity Ratio
-1.300.170.260.140.080.09
Upgrade
Net Debt / Equity Ratio
5.28-1.20-0.98-0.99-0.92-0.81
Upgrade
Net Debt / EBITDA Ratio
0.460.740.930.891.243.09
Upgrade
Net Debt / FCF Ratio
0.460.790.921.021.702.08
Upgrade
Asset Turnover
0.000.000.000.020.000.02
Upgrade
Quick Ratio
0.742.703.472.736.2310.33
Upgrade
Current Ratio
0.792.773.603.256.8211.30
Upgrade
Return on Equity (ROE)
-328.45%-115.42%-79.55%-89.97%-70.55%-71.79%
Upgrade
Return on Assets (ROA)
-63.56%-49.45%-30.50%-37.53%-36.35%-22.68%
Upgrade
Return on Capital Employed (ROCE)
20471.70%-144.30%-98.70%-100.80%-70.00%-24.90%
Upgrade
Earnings Yield
-90.94%-162.35%-97.05%-71.89%-28.93%-11.10%
Upgrade
FCF Yield
-74.95%-158.28%-89.56%-55.80%-20.66%-11.97%
Upgrade
Buyback Yield / Dilution
-53.38%-22.49%-11.51%-14.27%-34.62%-57.14%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.